Novel PCSK9 Inhibitor Cut LDL Cholesterol Levels by More Than Half
DAIC
APRIL 7, 2024
milla1cf Sun, 04/07/2024 - 18:09 April 7, 2024 — Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or “bad” cholesterol, levels by more than half on average, compared with a placebo.
Let's personalize your content